| VIRX Stock | | | USD 0.16 0.01 6.67% |
Viracta Therapeutics financial indicator trend analysis is much more than just breaking down Viracta Therapeutics prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Viracta Therapeutics is a good investment. Please check the relationship between Viracta Therapeutics Cash And Short Term Investments and its Common Stock Shares Outstanding accounts. Check out
World Market Map to better understand how to build diversified portfolios, which includes a position in Viracta Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as
signals in metropolitan statistical area.
For more information on how to buy Viracta Stock please use our
How to Invest in Viracta Therapeutics guide.
Cash And Short Term Investments vs Common Stock Shares Outstanding
Cash And Short Term Investments vs Common Stock Shares Outstanding Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of
Viracta Therapeutics Cash And Short Term Investments account and
Common Stock Shares Outstanding. At this time, the significance of the direction appears to have fragmental relationship.
The correlation between Viracta Therapeutics' Cash And Short Term Investments and Common Stock Shares Outstanding is 0.59. Overlapping area represents the amount of variation of Cash And Short Term Investments that can explain the historical movement of Common Stock Shares Outstanding in the same time period over historical financial statements of Viracta Therapeutics, assuming nothing else is changed. The correlation between historical values of Viracta Therapeutics' Cash And Short Term Investments and Common Stock Shares Outstanding is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Cash And Short Term Investments of Viracta Therapeutics are associated (or correlated) with its Common Stock Shares Outstanding. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Common Stock Shares Outstanding has no effect on the direction of Cash And Short Term Investments i.e., Viracta Therapeutics' Cash And Short Term Investments and Common Stock Shares Outstanding go up and down completely randomly.
Correlation Coefficient | 0.59 |
| Relationship Direction | Positive |
| Relationship Strength | Weak |
Cash And Short Term Investments
Short Term Investments is an account in the current assets section of Viracta Therapeutics balance sheet. This account contains Viracta Therapeutics investments that will expire within one year. These investments include stocks and bonds that can be liquidated by Viracta Therapeutics fairly quickly. The sum of a company's cash on hand, including bank deposits and short-term, highly liquid investments that are easily convertible to known amounts of cash.
Common Stock Shares Outstanding
The total number of shares of a company's common stock that are currently owned by all its shareholders.
Most indicators from Viracta Therapeutics' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Viracta Therapeutics current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out
World Market Map to better understand how to build diversified portfolios, which includes a position in Viracta Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as
signals in metropolitan statistical area.
For more information on how to buy Viracta Stock please use our
How to Invest in Viracta Therapeutics guide.
Sales General And Administrative To Revenue is likely to rise to 53.81 in 2024, whereas
Selling General Administrative is likely to drop slightly above 13.7
M in 2024.
Viracta Therapeutics fundamental ratios Correlations
Click cells to compare fundamentals
Viracta Therapeutics Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Viracta Therapeutics fundamental ratios Accounts
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
Additional Tools for Viracta Stock Analysis
When running Viracta Therapeutics' price analysis, check to
measure Viracta Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Viracta Therapeutics is operating at the current time. Most of Viracta Therapeutics' value examination focuses on studying past and present price action to
predict the probability of Viracta Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Viracta Therapeutics' price. Additionally, you may evaluate how the addition of Viracta Therapeutics to your portfolios can decrease your overall portfolio volatility.